期刊文献+

血清壳多糖酶3样蛋白1在肝病及其他疾病中的应用价值

下载PDF
导出
摘要 壳多糖酶3样蛋白1,又名几丁质酶3样蛋白1,是几丁质酶家族成员之一,不具酶活性,主要在肝脏星状细胞和巨噬细胞中表达,是分泌到肝脏的细胞外基质,血清中的含量与肝脏组织中成正相关,对各种病因引起的肝纤维化诊断具有较好的诊断价值,能动态监测肝纤维化,并且在肝纤维化、肝硬化、肝癌进展过程中会出现不同程度的升高。因此,通过检测壳酶蛋白,有利于早期识别肝纤维化分期,进而实施干预,延缓甚至逆转肝纤维化的进展。此外,壳酶蛋白在多种恶性肿瘤及其他疾病中也有一定的应用价值。本文就壳酶蛋白在肝病及其他疾病中的作用作一综述,为临床相关疾病的诊治提供参考。
出处 《现代消化及介入诊疗》 2023年第12期1467-1470,1474,共5页 Modern Interventional Diagnosis and Treatment in Gastroenterology
基金 国家自然科学基金项目(82360108) 云南省医学领军人才项目(L-2019013) 云南万人计划名医专项(YNWR-MY-2018-028) 云南省科技人才与平台计划(院士专家工作站202305AF150065) 昆明医科大学第二附属医院临床研究项目(2020ynlc010,ynIIT2021017)。
  • 相关文献

参考文献7

二级参考文献71

  • 1屈小勇,王毅,刘艳萍.原发性肝癌手术治疗联合介入治疗临床疗效观察分析[J].医学信息(医学与计算机应用),2014,0(16):393-393. 被引量:2
  • 2Yukiko Saitou,Katsuya Shiraki,Yutaka Yamanaka,Yumi Yamaguchi,Tomoyuki Kawakita,Norihiko Yamamoto,Kazushi Sugimoto,Kazumoto Murata,Takeshi Nakano.Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease[J].World Journal of Gastroenterology,2005,11(4):476-481. 被引量:21
  • 3Forns X, Ampurdanes S, Sanchez-Tapias JM, Guilera M, Sans M, Sanchez-Fueyo A. Quinto L, Joya P, Bruguera M, Rodes J.Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 2001; 35:265-271.
  • 4Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23; 1334-1340.
  • 5Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For thegroup of epidemiology of the french association for the study of the liver (AFEF). Hepatology 2000; 32:477-481.
  • 6Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatololgy 2003; 38:518-526.
  • 7Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M,Caballeria J, Ballesta AM, Rodes J. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatoloyg 1996; 24:1399-1403.
  • 8Nojgaard C, Johansen JS, Cl~ristensen E, Skovgaard LT, Price PA, Becker U. EMALD group. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 2003; 2:179-186.
  • 9Nojgaard C,Johansen JS, Krarup HB, Holten-Andersen M,Moiler A, Bendtsen F. Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C. Scand J Gastroenterol 2003; 38:659-665.
  • 10Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol 1996; 24:148-154.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部